British university teacher known for his contributions to academic research.
The FDA has approved Eli Lilly's new oral GLP-1 weight-loss medication, Foundayo, for adults with obesity or overweight. This approval introduces a convenient pill option that could significantly shift weight management treatments and market dynamics.
